Edition:
United Kingdom

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

0.38USD
16 Oct 2018
Change (% chg)

$0.01 (+2.70%)
Prev Close
$0.37
Open
$0.37
Day's High
$0.41
Day's Low
$0.37
Volume
46,017
Avg. Vol
32,434
52-wk High
$2.97
52-wk Low
$0.31

Chart for

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -0.71
Market Cap(Mil.): $25.24
Shares Outstanding(Mil.): 14.43
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -1.86 -- --
ROI: -143.79 0.73 14.32
ROE: -221.11 1.82 16.04

Earnings vs. Estimates